Skip to main content
Erschienen in: Neuroradiology 4/2022

09.09.2021 | Diagnostic Neuroradiology

Smoldering lesions in MS: if you like it then you should put a rim on it

verfasst von: Catarina Pinto, Melissa Cambron, Adrienn Dobai, Eva Vanheule, Jan W. Casselman

Erschienen in: Neuroradiology | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In multiple sclerosis (MS), chronic active/smoldering white matter lesions presenting with hypointense rims on susceptibility-weighted imaging (SWI) of the brain have been recognized as an important radiological feature. The aim of this work was to study the prevalence of paramagnetic rim lesions (RLs) in MS patients in a clinical setting and to assess differences in demographic and clinical variables regarding the presence of RLs.

Methods

All 3 T brain magnetic resonance (MR) studies performed in MS patients between July 2020 and January 2021 were reviewed. In all patients, RLs were assessed on three-dimensional (3D) SWI images and the T2 FLAIR lesion load volume was assessed. Demographic, laboratory (oligoclonal bands in CSF), and clinical data, including functional status with Expanded Disability Status Scale (EDSS), were retrieved from the clinical files.

Results

Of the 192 patients, 113 (59%) presented with at least 1 RL. In the RL-positive group, the mean RL count was 4.81 ranging from 1 to 37. There was no significant difference in the number of RLs between the different types of MS (p = 0.858). Regarding the presence of RLs, there were no significant differences based on gender (p = 0.083), disease duration (p = 0.520), treatment regime (p = 0.326), EDSS score (p = 0.103), and the associated T2 FLAIR lesion load volume.

Conclusion

SWI RLs were frequently detected in our cohort regardless of the MS type, T2 FLAIR lesion load volume, demographic features, disease duration, or clinical score. Our results suggest that RLs are not associated with more severe forms of the disease. Today, RLs can be seen on 3 T 3D SWI, although this is not a clinical standard sequence yet. Therefore, it should be considered an additional helpful MR sequence in the diagnostic workup of MS, although more studies are warranted to establish the role of RLs as prognostic markers.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
6.
Zurück zum Zitat Clarke MA, Samaraweera AP, Falah Y, Pitiot A, Allen CM, Dineen RA, Tench CR, Morgan PS, Evangelou N (2020) Single Test to ARrive at Multiple Sclerosis (STAR-MS) diagnosis: a prospective pilot study assessing the accuracy of the central vein sign in predicting multiple sclerosis in cases of diagnostic uncertainty. Mult Scler 26:433–441. https://doi.org/10.1177/1352458519882282CrossRefPubMed Clarke MA, Samaraweera AP, Falah Y, Pitiot A, Allen CM, Dineen RA, Tench CR, Morgan PS, Evangelou N (2020) Single Test to ARrive at Multiple Sclerosis (STAR-MS) diagnosis: a prospective pilot study assessing the accuracy of the central vein sign in predicting multiple sclerosis in cases of diagnostic uncertainty. Mult Scler 26:433–441. https://​doi.​org/​10.​1177/​1352458519882282​CrossRefPubMed
7.
10.
16.
23.
Zurück zum Zitat Maggi P, Sati P, Nair G, Cortese ICM, Jacobson S, Smith BR, Nath A, Ohayon J, van Pesch V, Perrotta G, Pot C, Theaudin M, Martinelli V, Scotti R, Wu T, Du Pasquier R, Calabresi PA, Filippi M, Reich DS, Absinta M (2020) Paramagnetic rim lesions are specific to multiple sclerosis: an international multicenter 3T MRI study. Ann Neurol 88:1034–1042. https://doi.org/10.1002/ana.25877CrossRefPubMed Maggi P, Sati P, Nair G, Cortese ICM, Jacobson S, Smith BR, Nath A, Ohayon J, van Pesch V, Perrotta G, Pot C, Theaudin M, Martinelli V, Scotti R, Wu T, Du Pasquier R, Calabresi PA, Filippi M, Reich DS, Absinta M (2020) Paramagnetic rim lesions are specific to multiple sclerosis: an international multicenter 3T MRI study. Ann Neurol 88:1034–1042. https://​doi.​org/​10.​1002/​ana.​25877CrossRefPubMed
25.
Zurück zum Zitat Blindenbacher N, Brunner E, Asseyer S, Scheel M, Siebert N, Rasche L, Bellmann-Strobl J, Brandt A, Ruprecht K, Meier D, Wuerfel J, Paul F, Sinnecker T (2020) Evaluation of the “ring sign” and the “core sign” as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis. Mult Scler J Exp Transl Clin 6:2055217320915480. https://doi.org/10.1177/2055217320915480CrossRefPubMedPubMedCentral Blindenbacher N, Brunner E, Asseyer S, Scheel M, Siebert N, Rasche L, Bellmann-Strobl J, Brandt A, Ruprecht K, Meier D, Wuerfel J, Paul F, Sinnecker T (2020) Evaluation of the “ring sign” and the “core sign” as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis. Mult Scler J Exp Transl Clin 6:2055217320915480. https://​doi.​org/​10.​1177/​2055217320915480​CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Hagemeier J, Weinstock-Guttman B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Magnano C, Hojnacki D, Dwyer MG, Zivadinov R (2012) Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy. AJNR Am J Neuroradiol 33:1596–1601. https://doi.org/10.3174/ajnr.A3030CrossRefPubMedPubMedCentral Hagemeier J, Weinstock-Guttman B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Magnano C, Hojnacki D, Dwyer MG, Zivadinov R (2012) Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy. AJNR Am J Neuroradiol 33:1596–1601. https://​doi.​org/​10.​3174/​ajnr.​A3030CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintore M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173. https://doi.org/10.1016/S1474-4422(17)30470-2CrossRefPubMed Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintore M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173. https://​doi.​org/​10.​1016/​S1474-4422(17)30470-2CrossRefPubMed
28.
Zurück zum Zitat Lorscheider J, Buzzard K, Jokubaitis V, Spelman T, Havrdova E, Horakova D, Trojano M, Izquierdo G, Girard M, Duquette P, Prat A, Lugaresi A, Grand’Maison F, Grammond P, Hupperts R, Alroughani R, Sola P, Boz C, Pucci E, Lechner-Scott J, Bergamaschi R, Oreja-Guevara C, Iuliano G, Van Pesch V, Granella F, Ramo-Tello C, Spitaleri D, Petersen T, Slee M, Verheul F, Ampapa R, Amato MP, McCombe P, Vucic S, Sánchez Menoyo JL, Cristiano E, Barnett MH, Hodgkinson S, Olascoaga J, Saladino ML, Gray O, Shaw C, Moore F, Butzkueven H, Kalincik T, MSBase Study Group (2016) Defining secondary progressive multiple sclerosis. Brain 139:2395–2405. https://doi.org/10.1093/brain/aww173CrossRefPubMed Lorscheider J, Buzzard K, Jokubaitis V, Spelman T, Havrdova E, Horakova D, Trojano M, Izquierdo G, Girard M, Duquette P, Prat A, Lugaresi A, Grand’Maison F, Grammond P, Hupperts R, Alroughani R, Sola P, Boz C, Pucci E, Lechner-Scott J, Bergamaschi R, Oreja-Guevara C, Iuliano G, Van Pesch V, Granella F, Ramo-Tello C, Spitaleri D, Petersen T, Slee M, Verheul F, Ampapa R, Amato MP, McCombe P, Vucic S, Sánchez Menoyo JL, Cristiano E, Barnett MH, Hodgkinson S, Olascoaga J, Saladino ML, Gray O, Shaw C, Moore F, Butzkueven H, Kalincik T, MSBase Study Group (2016) Defining secondary progressive multiple sclerosis. Brain 139:2395–2405. https://​doi.​org/​10.​1093/​brain/​aww173CrossRefPubMed
29.
Zurück zum Zitat Okuda DT, Siva A, Kantarci O, Inglese M, Katz I, Tutuncu M, Keegan BM, Donlon S, Hua LH, Vidal-Jordana A, Montalban X, Rovira A, Tintoré M, Amato MP, Brochet B, de Seze J, Brassat D, Vermersch P, De Stefano N, Sormani MP, Pelletier D, Lebrun C, Radiologically Isolated Syndrome C, Club Francophone de la Sclérose en Plaques (2014) Radiologically isolated syndrome: 5-year risk for an initial clinical event. PloS One 9:e90509–e90509. https://doi.org/10.1371/journal.pone.0090509CrossRefPubMedPubMedCentral Okuda DT, Siva A, Kantarci O, Inglese M, Katz I, Tutuncu M, Keegan BM, Donlon S, Hua LH, Vidal-Jordana A, Montalban X, Rovira A, Tintoré M, Amato MP, Brochet B, de Seze J, Brassat D, Vermersch P, De Stefano N, Sormani MP, Pelletier D, Lebrun C, Radiologically Isolated Syndrome C, Club Francophone de la Sclérose en Plaques (2014) Radiologically isolated syndrome: 5-year risk for an initial clinical event. PloS One 9:e90509–e90509. https://​doi.​org/​10.​1371/​journal.​pone.​0090509CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Philips (2019) IntelliSpace Portal 9 LOBI COBI. 8 Philips (2019) IntelliSpace Portal 9 LOBI COBI. 8
33.
37.
Zurück zum Zitat al TAe (2021) Efficacy and safety of tolebrutinib in patients with highly active relapsing MS: subgroup analysis of the phase 2b study. AAN 2021 al TAe (2021) Efficacy and safety of tolebrutinib in patients with highly active relapsing MS: subgroup analysis of the phase 2b study. AAN 2021
38.
Zurück zum Zitat Filippi M, Bruck W, Chard D, Fazekas F, Geurts JJG, Enzinger C, Hametner S, Kuhlmann T, Preziosa P, Rovira A, Schmierer K, Stadelmann C, Rocca MA, Attendees of the Correlation between P, workshop MRIfiM (2019) Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol 18:198–210. https://doi.org/10.1016/S1474-4422(18)30451-4CrossRefPubMed Filippi M, Bruck W, Chard D, Fazekas F, Geurts JJG, Enzinger C, Hametner S, Kuhlmann T, Preziosa P, Rovira A, Schmierer K, Stadelmann C, Rocca MA, Attendees of the Correlation between P, workshop MRIfiM (2019) Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol 18:198–210. https://​doi.​org/​10.​1016/​S1474-4422(18)30451-4CrossRefPubMed
41.
Zurück zum Zitat Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N, Pitiot A, Giorgio A, Schoonheim MM, Paul F, Pawlak MA, Schmidt R, Kappos L, Montalban X, Rovira A, Evangelou N, Wuerfel J, Group MS (2019) Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis. JAMA Neurol 76:1446–1456. https://doi.org/10.1001/jamaneurol.2019.2478CrossRefPubMed Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N, Pitiot A, Giorgio A, Schoonheim MM, Paul F, Pawlak MA, Schmidt R, Kappos L, Montalban X, Rovira A, Evangelou N, Wuerfel J, Group MS (2019) Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis. JAMA Neurol 76:1446–1456. https://​doi.​org/​10.​1001/​jamaneurol.​2019.​2478CrossRefPubMed
43.
Zurück zum Zitat Wattjes MP, Ciccarelli O, Reich DS, Banwell B, de Stefano N, Enzinger C, Fazekas F, Filippi M, Frederiksen J, Gasperini C, Hacohen Y, Kappos L, Li DKB, Mankad K, Montalban X, Newsome SD, Oh J, Palace J, Rocca MA, Sastre-Garriga J, Tintoré M, Traboulsee A, Vrenken H, Yousry T, Barkhof F, Rovira À. (2021) 2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol https://doi.org/10.1016/S1474-4422(21)00095-8 Wattjes MP, Ciccarelli O, Reich DS, Banwell B, de Stefano N, Enzinger C, Fazekas F, Filippi M, Frederiksen J, Gasperini C, Hacohen Y, Kappos L, Li DKB, Mankad K, Montalban X, Newsome SD, Oh J, Palace J, Rocca MA, Sastre-Garriga J, Tintoré M, Traboulsee A, Vrenken H, Yousry T, Barkhof F, Rovira À. (2021) 2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol https://​doi.​org/​10.​1016/​S1474-4422(21)00095-8
Metadaten
Titel
Smoldering lesions in MS: if you like it then you should put a rim on it
verfasst von
Catarina Pinto
Melissa Cambron
Adrienn Dobai
Eva Vanheule
Jan W. Casselman
Publikationsdatum
09.09.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Neuroradiology / Ausgabe 4/2022
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-021-02800-0

Weitere Artikel der Ausgabe 4/2022

Neuroradiology 4/2022 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.